2-[(3-bromo-5-iodo-4-propan-2-ylpyrazol-1-yl)methoxy]ethyl-trimethylsilane
C12H22BrIN2OSi — CID 156733839
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(3-bromo-5-iodo-4-propan-2-ylpyrazol-1-yl)methoxy]ethyl-trimethylsilane
2-[(3-bromo-5-iodo-4-propan-2-ylpyrazol-1-yl)methoxy]ethyl-trimethylsilane (PubChem CID 156733839) has the molecular formula C12H22BrIN2OSi and a molecular weight of 445.22 g/mol. Its IUPAC name is 2-[(3-bromo-5-iodo-4-propan-2-ylpyrazol-1-yl)methoxy]ethyl-trimethylsilane.
Molecular Properties
| Compound Name | 2-[(3-bromo-5-iodo-4-propan-2-ylpyrazol-1-yl)methoxy]ethyl-trimethylsilane |
|---|---|
| PubChem CID | 156733839 |
| Molecular Formula | C12H22BrIN2OSi |
| Molecular Weight | 445.22 g/mol |
| Exact Mass | 443.97 |
| IUPAC Name | 2-[(3-bromo-5-iodo-4-propan-2-ylpyrazol-1-yl)methoxy]ethyl-trimethylsilane |
| SMILES | CC(C)c1c(Br)nn(COCC[Si](C)(C)C)c1I |
| InChI | InChI=1S/C12H22BrIN2OSi/c1-9(2)10-11(13)15-16(12(10)14)8-17-6-7-18(3,4)5/h9H,6-8H2,1-5H3 |
| InChIKey | PSACVWFFIMYPEK-UHFFFAOYSA-N |
| XLogP | 4.69 |
| TPSA | 27.05 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 18 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 445.22 |
| LogP ≤ 5 | 4.69 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156733839 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.